Michael J. Warmuth, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 27,533 shares at $56.75 ($1.6M) on 2012-03-01, disclosed to the SEC on 2012-03-02.
Scheduled sale ($1.6M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.04 | 9,077 | $518K | 33.1% |
| 2 | $56.72 | 2,059 | $117K | 7.5% |
| 3 | $56.73 | 2,952 | $167K | 10.7% |
| 4 | $56.74 | 352 | $20K | 1.3% |
| 5 | $56.75 | 7,048 | $400K | 25.6% |
| 6 | $56.76 | 1,700 |
| $96K |
| 6.2% |
| 7 | $56.76 | 200 | $11K | 0.7% |
| 8 | $56.77 | 4,145 | $235K | 15.0% |
| Total | $56.84 avg | 27,533 | $1.6M | 100% |
| Filing → |
| ABT | SELL | 2016-03-02 | $474K | — | Filing → |
| ABT | SELL | 2015-03-12 | $627K | — | Filing → |
| ABT | SELL | 2014-03-04 | $643K | — | Filing → |